HIV clinical trials in Georgia
14 studies for HIV are looking for participants at sites in Georgia.
Cities in Georgia
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Faebris Medical & Community Education, Atlanta
- Grady Memorial Hospital, Atlanta
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Decatur
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Metro Infectious Diseases Consultants L.L.C. ( Site 1509), Decatur
- Mercer university, Department of internal medicine-Clinical Research ( Site 1512), Macon
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266831Screen2Prevent (S2P)
- Emory Atlanta Adolescent Consortium, Atlanta
RecruitingHealthy volunteers welcome
Ages 14 to 24 · All sexes · Updated Aug 17, 2026 · NCT07728123Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Atlanta ID Group, PC, Atlanta
- Chatham County Health Department, Savannah
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT07682961A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Atlanta
- GSK Investigational Site, Macon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07202546Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
- Emory Children's Center ( Site 0103), Atlanta
RecruitingPhase 2
4 Weeks – 11 Years · All sexes · Updated Jul 8, 2026 · NCT04375800Inflammation and Depression in People With HIV
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 28, 2026 · NCT05849038Menopausal HT for Women Living With HIV (HoT)
- The Ponce de Leon Center CRS (5802), Atlanta
RecruitingPhase 4
Ages 40 to 60 · Women · Updated May 22, 2026 · NCT06856174Low Dose Naltrexone for Pain in Patients With HIV
- Grady Memorial Hospital, Atlanta
- Emory Midtown Hospital, Atlanta
- Emory University Hospital, Atlanta
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Apr 9, 2026 · NCT05537935Baricitinib for Reduction of HIV - CNS
- Grady Memorial Hospital, Atlanta
- Emory University Hospital, Atlanta
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Mar 23, 2026 · NCT05452564Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
- Ponce de Leon Center CRS, Atlanta
- The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Sep 25, 2025 · NCT06796686HIV Treatment Adherence Dose Determination Trial
- University of Connecticut Field Site, Atlanta
Recruiting
Ages 18 and older · All sexes · Updated Aug 29, 2025 · NCT04577313Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Atlanta
RecruitingPhase 1/2
Ages 6 to 12 · All sexes · Updated Sep 19, 2024 · NCT05674656From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.